WallStreetZenWallStreetZen

NASDAQ: ICLR
Icon PLC Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for ICLR

Based on 9 analysts offering 12 month price targets for Icon PLC.
Min Forecast
$235.00+28.24%
Avg Forecast
$265.22+44.73%
Max Forecast
$290.00+58.25%

Should I buy or sell ICLR stock?

Based on 9 analysts offering ratings for Icon PLC.
Buy
Strong Buy
5 analysts 55.56%
Buy
0 analysts 0%
Hold
4 analysts 44.44%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ICLR stock forecasts and price targets.

ICLR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 8%
8
HoldMaintains$240.00+30.97%2022-09-12
UBS
Bottom 21%
21
Strong BuyInitiates Coverage On$270.00+47.34%2022-09-07
Credit Suisse
Top 8%
93
HoldInitiates Coverage On$260.00+41.88%2022-08-25
Deutsche Bank
Bottom 27%
27
Strong BuyMaintains$285.00+55.53%2022-07-14
Citigroup
Top 5%
96
Strong BuyMaintains$290.00+58.25%2022-07-08
Guggenheim
Top 6%
95
Strong BuyInitiates Coverage On$285.00+55.53%2022-05-24
Wells Fargo
Bottom 21%
21
HoldDowngrades$250.00+36.43%2022-04-25
Mizuho
Bottom 34%
34
Strong BuyMaintains$272.00+48.43%2022-03-07
Deutsche Bank
Top 9%
92
HoldMaintains$235.00+28.24%2022-02-25
Anonymous
Barclays
HoldMaintains$315.00+71.90%2021-11-05

1 of 1

Forecast return on equity

Is ICLR forecast to generate an efficient return?
Company
16.79%
Industry
60.04%
Market
119.16%
ICLR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ICLR forecast to generate an efficient return on assets?
Company
8.03%
Industry
13.96%
ICLR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ICLR earnings per share forecast

What is ICLR's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.61+297.38%
Avg 2 year Forecast
$12.62+372.66%
Avg 3 year Forecast
$14.57+445.69%
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ICLR revenue forecast

What is ICLR's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$7.8B+2.16%
Avg 2 year Forecast
$8.3B+10.03%
Avg 3 year Forecast
$9.1B+19.5%
ICLR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ICLR earnings growth forecast

How is ICLR forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
76.1%
Industry
25.45%
Market
16.69%
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ICLR's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ICLR revenue growth forecast

How is ICLR forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
6.02%
Industry
8.25%
Market
8.53%
ICLR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ICLR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ICLR vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
ICLR$183.25$265.22+44.73%Buy
PKI$118.07$168.89+43.04%Hold
DGX$122.31$147.36+20.48%Hold
WAT$270.49$343.33+26.93%Hold
PHG$14.94N/AN/ABuy
View Top Diagnostic & Research Stocks

Icon Stock Forecast FAQ

Is Icon Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: ICLR) stock is to Buy ICLR stock.

Out of 9 analysts, 5 (55.56%) are recommending ICLR as a Strong Buy, 0 (0%) are recommending ICLR as a Buy, 4 (44.44%) are recommending ICLR as a Hold, 0 (0%) are recommending ICLR as a Sell, and 0 (0%) are recommending ICLR as a Strong Sell.

If you're new to stock investing, here's how to buy Icon stock.

What is ICLR's earnings growth forecast for 2022-2024?

(NASDAQ: ICLR) Icon's forecast annual earnings growth rate of 76.1% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 25.45%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.69%.

Icon's earnings in 2022 is $209,902,000.On average, 1 Wall Street analyst forecast ICLR's earnings for 2022 to be $864,997,300, with the lowest ICLR earnings forecast at $864,997,300, and the highest ICLR earnings forecast at $864,997,300. On average, 1 Wall Street analyst forecast ICLR's earnings for 2023 to be $1,028,865,780, with the lowest ICLR earnings forecast at $1,028,865,780, and the highest ICLR earnings forecast at $1,028,865,780.

In 2024, ICLR is forecast to generate $1,187,842,664 in earnings, with the lowest earnings forecast at $1,187,842,664 and the highest earnings forecast at $1,187,842,664.

What is ICLR's revenue growth forecast for 2022-2024?

(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 6.02% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.53%.

Icon's revenue in 2022 is $7,588,430,000.On average, 4 Wall Street analysts forecast ICLR's revenue for 2022 to be $632,032,085,810, with the lowest ICLR revenue forecast at $628,304,363,231, and the highest ICLR revenue forecast at $635,121,618,109. On average, 4 Wall Street analysts forecast ICLR's revenue for 2023 to be $680,693,034,783, with the lowest ICLR revenue forecast at $676,678,501,601, and the highest ICLR revenue forecast at $686,711,655,018.

In 2024, ICLR is forecast to generate $739,303,164,768 in revenue, with the lowest revenue forecast at $735,183,462,263 and the highest revenue forecast at $741,551,342,483.

What is ICLR's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: ICLR) forecast ROA is 8.03%, which is lower than the forecast US Diagnostics & Research industry average of 13.96%.

What is ICLR's Price Target?

According to 9 Wall Street analysts that have issued a 1 year ICLR price target, the average ICLR price target is $265.22, with the highest ICLR stock price forecast at $290.00 and the lowest ICLR stock price forecast at $235.00.

On average, Wall Street analysts predict that Icon's share price could reach $265.22 by Sep 12, 2023. The average Icon stock price prediction forecasts a potential upside of 44.73% from the current ICLR share price of $183.25.

What is ICLR's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: ICLR) Icon's current Earnings Per Share (EPS) is $2.67. On average, analysts forecast that ICLR's EPS will be $10.61 for 2022, with the lowest EPS forecast at $10.61, and the highest EPS forecast at $10.61. On average, analysts forecast that ICLR's EPS will be $12.62 for 2023, with the lowest EPS forecast at $12.62, and the highest EPS forecast at $12.62. In 2024, ICLR's EPS is forecast to hit $14.57 (min: $14.57, max: $14.57).

What is ICLR's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: ICLR) forecast ROE is 16.79%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.